207 related articles for article (PubMed ID: 11750464)
1. Obese kidney transplant recipients have good outcomes.
Howard RJ; Thai VB; Patton PR; Hemming AW; Reed AI; Van der Werf WJ; Fujita S; Karlix JL; Scornik JC
Transplant Proc; 2001; 33(7-8):3420-1. PubMed ID: 11750464
[No Abstract] [Full Text] [Related]
2. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Kanematsu A; Oshima T; Harano M; Inui M; Yagisawa T; Nakajima I; Fuchinoue S; Takahashi K; Toma H
Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
[No Abstract] [Full Text] [Related]
3. The impact of pre-transplant obesity on renal transplant outcomes.
Drafts HH; Anjum MR; Wynn JJ; Mulloy LL; Bowley JN; Humphries AL
Clin Transplant; 1997 Oct; 11(5 Pt 2):493-6. PubMed ID: 9361948
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of living-unrelated donor kidney transplantation.
Prabhakar KS; Vathsala A; Woo KT
Transplant Proc; 2000 Nov; 32(7):1807-8. PubMed ID: 11119945
[No Abstract] [Full Text] [Related]
5. Selective CellCept therapy in high-risk renal transplant recipients.
Isenberg A; Singh TP; Shen GK; Freed BM; Conti DJ
Transplant Proc; 1998 Jun; 30(4):1188-9. PubMed ID: 9636480
[No Abstract] [Full Text] [Related]
6. Kidney transplantation at one center: 1-year results.
Haberal M; Bilgin N; Karakayali H; Arslan G; Büyükpamukçu N; Velidedeoğlu E; Turan M; Akkoç H; Moray G; Tezel E
Transplant Proc; 1996 Feb; 28(1):410-1. PubMed ID: 8644295
[No Abstract] [Full Text] [Related]
7. Impact of delayed graft function on cadaveric kidney transplant outcome.
Gentil MA; Alcaide MP; Algarra GR; Pereira P; Toro J; González-Roncero F; López M; Bernal G; Mateos J
Transplant Proc; 2003 Mar; 35(2):689-91. PubMed ID: 12644095
[No Abstract] [Full Text] [Related]
8. Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.
MacDonald AS; Belitsky P; Bitter-Suermann H; Lawen J; MacSween M; Kiberd B; West K; McAlister VC
Transplant Proc; 1997; 29(1-2):190. PubMed ID: 9122958
[No Abstract] [Full Text] [Related]
9. Immunosuppressive protocols at transplantation centers in Turkey.
Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
[No Abstract] [Full Text] [Related]
10. Renal recipients of haploidentical living donors treated with Neoral or conventional cyclosporine: a comparative follow-up of 3 years.
Gracida C; Melchor JL
Transplant Proc; 1998 Aug; 30(5):1742-3. PubMed ID: 9723262
[No Abstract] [Full Text] [Related]
11. Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
Koay HC; Vathsala A; Woo KT
Transplant Proc; 2000 Nov; 32(7):1921-3. PubMed ID: 11120001
[No Abstract] [Full Text] [Related]
12. Increasing incidence of steroid resistant rejection in kidney transplantation.
Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
[No Abstract] [Full Text] [Related]
13. Living-related kidney transplantation using low-dose triple immunosuppression.
Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
[No Abstract] [Full Text] [Related]
14. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
[No Abstract] [Full Text] [Related]
15. Hyperamylasemia in kidney transplant recipients.
Yokoyama I; Hayashi S; Kobayashi T; Negita M; Katayama A; Nagasaka R; Namii Y; Kojima T; Koike C; Uchida K; Takagi H
Transplant Proc; 1996 Jun; 28(3):1476-7. PubMed ID: 8658748
[No Abstract] [Full Text] [Related]
16. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
[No Abstract] [Full Text] [Related]
17. Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
Shiroki R; Hoshinaga K; Tsukiashi Y; Higuchi T; Izumitani M; Horiba M; Naide Y
Transplant Proc; 1997 Dec; 29(8):3571-3. PubMed ID: 9414841
[No Abstract] [Full Text] [Related]
18. Living donor kidney transplantation in Japan.
Ota K
Transplant Proc; 1994 Aug; 26(4):2084-8. PubMed ID: 7520622
[No Abstract] [Full Text] [Related]
19. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
Tsai MK; Lee PH; Hu RH; Lee CJ
Transplant Proc; 1998 Nov; 30(7):3125-6. PubMed ID: 9838381
[No Abstract] [Full Text] [Related]
20. Quality of life after cadaveric renal transplantation from a non-heart-beating donor.
Shimada H; Sakamoto K; Hori S; Asano T; Suzuki T; Gunji Y; Nakajima K; Kenmochi T; Hayashi H; Takeda A; Arita S; Kashiwabara H; Yokoyama T; Ochiai T
Transplant Proc; 2000 Nov; 32(7):1606-7. PubMed ID: 11119857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
